Xin‐an Lu

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Xian Zhang, Xin‐an Lu, Junfang Yang et al. · Blood Advances · 2020 · 215 citations · Full text

Medicine, Hematology, Oncology +14

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

Zhitao Ying, Ting He, Xiaopei Wang et al. · Molecular Therapy — Oncolytics · 2019 · 167 citations · Full text

Medicine, Immunology, Oncology +16

Synthesis of Heparin Oligosaccharides

Jinq‐Chyi Lee, Xin‐an Lu, Suvarn S. Kulkarni et al. · Journal of the American Chemical Society · 2003 · 150 citations

Life Sciences, Biochemistry, Carbohydrate Biochemistry +11

Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia

Xiangyu Zhao, Junfang Yang, Xian Zhang et al. · Molecular Therapy — Oncolytics · 2020 · 126 citations · Full text

Life Sciences, Immunology, Oncology +17

The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis

Wei Zhuo, Lin Jia, Nan Song et al. · Clinical Cancer Research · 2012 · 112 citations

Medicine, Cancer Biology, Oncology +17